Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking […]
John B. Sanfilippo & Son, Inc. 4th Quarter and Fiscal 2020 Year-End Operating Results Conference Call
Elgin, IL, Aug. 12, 2020 (GLOBE NEWSWIRE) — John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS), a major processor and […]
TSX News -
ECN Capital Reports US$0.07 in Adjusted Net Income per Common Share in Q2-2020
TORONTO, Aug. 12, 2020 (GLOBE NEWSWIRE) — ECN Capital Corp. (TSX: ECN) (“ECN Capital” or the “Company”) today reported financial […]
TSX News -
Condor Announces 2020 Second Quarter Results
CALGARY, Alberta, Aug. 12, 2020 (GLOBE NEWSWIRE) — Condor Petroleum Inc. (“Condor” or the “Company”) (TSX: CPI), a Canadian based […]
Rosetta Stone Launches New Program Empowering Emergent Bilinguals in Grades K-6 to Acquire Higher Language Proficiency Levels of English
Arlington, VA, Aug. 12, 2020 (GLOBE NEWSWIRE) —According to the National Education Association, in five years, Emergent Bilinguals, also known […]
Ballantyne Strong Reports Second Quarter 2020 Operating Results
Charlotte, NC, Aug. 12, 2020 (GLOBE NEWSWIRE) — Ballantyne Strong, Inc. (NYSE American: BTN) (the “Company”) today announced financial results for […]
One Medical Introduces One Medical Now Virtual Care
SAN FRANCISCO, Aug. 12, 2020 (GLOBE NEWSWIRE) — One Medical (Nasdaq: ONEM), a leading national digital health and primary care […]
One Medical Announces Plans to Enter North Carolina and Wisconsin
SAN FRANCISCO, Aug. 12, 2020 (GLOBE NEWSWIRE) — One Medical (NASDAQ: ONEM), a leading national technology-powered primary care organization, today […]
ClearPoint Neuro Reports Second Quarter 2020 Results
IRVINE, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) today announced financial results for its second […]
Eyenovia Reports Second Quarter 2020 Financial Results
NEW YORK, Aug. 12, 2020 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a […]
